Home » Authors » J. Alexander Bodkin, MD

J. Alexander Bodkin, MD

Director of the Clinical Psychopharmacology Research Program at McLean Hospital in Belmont, MA; assistant professor of psychiatry at Harvard Medical School

Articles

ARTICLES

Thinking Creatively About Treatment-Resistant Depression

April 1, 2016

J. Alexander Bodkin, MD

J. Alexander Bodkin, MD Director of the Clinical Psychopharmacology Research Program at McLean Hospital in Belmont, MA; assistant professor of psychiatry at Harvard Medical School Dr. Bodkin has disclosed that he has been a principal investigator in a study of brexpiprazole. Dr. Carlat has reviewed his interview and has found no evidence of bias in this educational activity.

Dr. Bodkin discusses methods for approaching treatment resistant depression and his perspective on depressive illness as a final common pathway for a number of different brain problems.

Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound
This comprehensive guide is designed to be a valuable resource for professionals working in...
READ MORE

General Psychiatry
KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything
Read More

General Psychiatry
Psychopharm Secrets: What Patients Won’t Tell You
How to assess med response when the patient reports is a poor guide: long-term mood stabilizers, sleep meds, and rapid cycling.
Listen now